Tirzepatide
Tirzepatide: a dual incretin therapy.
Tirzepatide works on both GIP and GLP-1 receptors — offering broader metabolic and appetite-regulation support for eligible adults under clinician supervision.
What it is
A once-weekly dual GIP and GLP-1 receptor agonist, used in metabolic care and in chronic weight management for eligible adults.
How it works
Activating two complementary hormone pathways often produces more pronounced appetite reduction and metabolic improvement than GLP-1 alone.
Who it may help
Adults considered eligible by a clinician for advanced metabolic and weight-management support, with no contraindications.
How MedAstra supports it
- Structured dose-day tracking and reminders
- Side-effect notes and appetite scores
- Calm, shame-free habit guidance — no streak pressure
Important to know
- GI side effects are common during dose escalation
- Requires ongoing medical monitoring
- Not appropriate for everyone — clinician decision
- Lifestyle change is still the foundation of long-term results
This page is educational only. It is not medical advice and should not be used to self-prescribe. Suitability for any GLP-1 medication — including semaglutide, Wegovy or tirzepatide — is determined by a qualified clinician based on your full medical history.
How treatment works
From signup to ongoing care, structured.
No guesswork, no medication-by-form. Each step takes minutes and builds on the last.
- 01
Eligibility assessment
A short structured questionnaire on weight, history and goals — designed to flag whether a clinician review makes sense.
- 02
Lifestyle & health evaluation
How you eat, sleep, move and work, plus existing conditions — so any plan fits your real life and medical context.
- 03
GLP-1 suitability review
A qualified clinician reviews your information and discusses whether GLP-1 therapy is appropriate, and what alternatives exist.
- 04
Personalized tracking setup
Habit anchors, dose-day reminders and a dashboard configured around your specific goal.
- 05
Ongoing progress monitoring
Side-effect tracking, appetite scores and clinician check-ins so the plan adapts as your body responds.
Considering tirzepatide for your plan?
Start with a structured eligibility check. No commitment, no pressure to begin medication.